Get to know our head of MAP program, Dr. Frank Theobald. In his 25 years at LTS, he has gained a great deal of knowledge in the field of drug delivery. Now, being head of our MAP program he drives forward our LTS proprietary program, customer projects as well as our CDMO business in the field of microneedle technologies. Learn about the results of the clinical studies with our MAPs containing Interferon-BETA and a Hepatitis-B-booster vaccine.
